Pfizer partners with Canada's drug research department; White House wants more research transparency;

 @DamianFierce: Despite the uptick in scrutiny, Indian clinical trial deaths were about the same in 2012 as in 2011. Story | Follow @DamianFierce

> As it continues to slash R&D spending around the world, Pfizer ($PFE) is partnering with the venture arm of Canada's Centre for Drug Research and Development, looking to speed the commercialization of new therapies. News

> The White House has issued a directive that will make more government-funded research publicly available. Story

> West Pharmaceutical is looking to shift its focus from contract manufacturing to proprietary products. Article

> Indian CRO GVK Biosciences is expanding in Taiwan, inking a distribution deal with that country's Genesis Genetics Asia. Release

> Clinical data contractor Medidata Solutions ($MDSO) has re-signed Purdue Pharma to a multi-year deal for its cloud-based clinical trial software. More

> According to a report from Industry Standard Research, the market for late-phase outsourced research is on the rise and will only continue its growth. Report

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.